p.112 抽出テキスト

1096. Donnellan E, Elshazly MB, Vakamudi S, Wazni OM, Cohen JA, Kanj M, et al. No association between CHADS-VASc score and left atrial appendage thrombus in patients with transthyretin amyloidosis. JACC Clin Electrophysiol 2019;5:1473–4. https://doi.org/10.1016/j.jacep.2019.10. 013 1097. Giancaterino S, Urey MA, Darden D, Hsu JC. Management of arrhythmias in cardiac amyloidosis. JACC Clin Electrophysiol 2020;6:351–61. https://doi. org/10.1016/j.jacep.2020.01.004 1098. El-Am EA, Dispenzieri A, Melduni RM, Ammash NM, White RD, Hodge DO, et al. Direct current cardioversion of atrial arrhythmias in adults with cardiac amyloidosis. J Am Coll Cardiol 2019;73:589–97. https://doi.org/10.1016/j. jacc.2018.10.079 1099. Cooper LT Jr, Keren A, Sliwa K, Matsumori A, Mensah GA. The global burden of myocarditis: part 1: a systematic literature review for the Global Burden of Diseases, Injuries, and Risk Factors 2010 study. Glob Heart 2014;9:121–9. https://doi.org/10.1016/j.gheart.2014.01.007 1100. Ammirati E, Cipriani M, Moro C, Raineri C, Pini D, Sormani P, et al. Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: multicenter Lombardy Registry. Circulation 2018;138: 1088–99. https://doi.org/10.1161/CIRCULATIONAHA.118.035319 1101. Anzini M, Merlo M, Sabbadini G, Barbati G, Finocchiaro G, Pinamonti B, et al. Long-term evolution and prognostic stratification of biopsy-proven active myocarditis. Circulation 2013;128:2384–94. https://doi.org/10.1161/ CIRCULATIONAHA.113.003092 1102. Ammirati E, Cipriani M, Lilliu M, Sormani P, Varrenti M, Raineri C, et al. Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis. Circulation 2017;136:529–45. https://doi.org/10. 1161/CIRCULATIONAHA.117.026386 1103. Ammirati E, Veronese G, Brambatti M, Merlo M, Cipriani M, Potena L, et al. Fulminant versus acute nonfulminant myocarditis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2019;74:299–311. https:// doi.org/10.1016/j.jacc.2019.04.063 1104. Baritussio A, Schiavo A, Basso C, Giordani AS, Cheng CY, Pontara E, et al. Predictors of relapse, death or heart transplantation in myocarditis before the introduction of immunosuppression: negative prognostic impact of female gender, fulminant onset, lower ejection fraction and serum autoantibodies. Eur J Heart Fail 2022;24:1033–44. https://doi.org/10.1002/ejhf.2496 1105. Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol 2010;56: 1149–57. https://doi.org/10.1016/j.jacc.2010.03.085 1106. Agarwal S, Sud K, Menon V. Nationwide hospitalization trends in adult congenital heart disease across 2003–2012. J Am Heart Assoc 2016;5: e002330. https://doi.org/10.1161/JAHA.115.002330 1107. Burstein DS, Rossano JW, Griffis H, Zhang X, Fowler R, Frischertz B, et al. Greater admissions, mortality and cost of heart failure in adults with congenital heart disease. Heart 2021;107:807–13. https://doi.org/10.1136/ heartjnl-2020-318246 1108. Arslani K, Roffler N, Zurek M, Greutmann M, Schwerzmann M, Bouchardy J, et al. Patterns of incidence rates of cardiac complications in patients with congenital heart disease. Can J Cardiol 2018;34:1624–30. https://doi.org/ 10.1016/j.cjca.2018.09.010 1109. Diller GP, Kempny A, Alonso-Gonzalez R, Swan L, Uebing A, Li W, et al. Survival prospects and circumstances of death in contemporary adult congenital heart disease patients under follow-up at a large tertiary centre. Circulation 2015;132:2118–25. https://doi.org/10.1161/ CIRCULATIONAHA.115.017202 1110. Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, van Dijk AP, et al. Mortality in adult congenital heart disease. Eur Heart J 2010; 31:1220–9. https://doi.org/10.1093/eurheartj/ehq032 1111. Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 2021;42:563–645. https://doi.org/10.1093/ eurheartj/ehaa554 1112. Lui GK, Saidi A, Bhatt AB, Burchill LJ, Deen JF, Earing MG, et al. Diagnosis and management of noncardiac complications in adults with congenital heart disease: a scientific statement from the American Heart Association. Circulation 2017;136:e348–92. https://doi.org/10.1161/CIR. 0000000000000535 1113. D’Alto M, Giannakoulas G, Aboulhosn J, Akagi T, Arvanitaki A, Badagliacca R, et al. Risk stratification for adult patients with pulmonary arterial hypertension associated with congenital heart disease. A scientific statement of the ESC Working Group on Pulmonary Circulation & Right Ventricular Function, the ESC Working Group on Adult Congenital Heart Disease, and the Association of Cardiovascular Nursing & Allied Professions of the ESC. Eur J Heart Fail 2026. https://doi.org/10.1093/ejhf/xuag059 Downloaded from academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehag100/8766302 by guest on 31 August 2026